Please assess the completion status of the following clinical trial:

Trial Title: High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patient, aged at least 18 years.~* Patient presenting with at least one autonomous hyperfunctioning thyroid nodule~  * TSH 0,1 mU/ml~ * Hyperfunctioning at thyroid scintigraphy with partial or total extinction of parenchyma~* Targeted nodules visible with ultrasonography~* Volume to be treated 15 cc~* Targeted area located at least at 2 mm from the trachea, the esophagus, and the carotid artery.~* Composition of the targeted nodule: no more than 75% cystic.~* Absence of abnormality at laryngoscopy in recurrent nerves~* Voluntary consent (patient or legal guardian) to participate in the study, following a full explanation of the nature and purpose of the study, by signing the Informed Consent document at the eligibility assessment visit~* Patients for whom iodine therapy is contra-indicated or unfeasible and surgery is contra-indicated or refused~* Patients refusing iodine therapy~* Willingness and availability to return for all required follow-up visits and to undergo all required study procedures.~* Patient affiliated to the French Health Insurance System~Exclusion Criteria:~* For the targeted nodule(s): presence of signs evidencing a nodule malignancy (compression or curvature of the surrounding organs, positive or suspicious previous FNAB).~* Suspicious cervical lymph nodes at US~* \> 75% Cystic nodule~* Macrocalcification inducing a shadow in the thyroid significant enough to preclude the HIFU treatment~* Pregnant or lactating woman. Female patient of childbearing age will be screened for pregnancy prior to enrollment in the study and will be included only if having a suitable contraception method.~* Known latex or lidocaine hypersensitivity~* History of neck irradiation or subtotal thyroidectomy~* Non controlled evolutive cardiothyreosis~* Patients treated with antithyroid medications within the month before the pre-treatment visit~* Subjects whose concurrent illnesses, disability, or geographical residence would hamper regular attendance at required study visits~* Patients who have received any investigational drug or device within the last 30 days and/or patients who are currently participating in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hifu (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).